Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6539589rdf:typepubmed:Citationlld:pubmed
pubmed-article:6539589lifeskim:mentionsumls-concept:C1384666lld:lifeskim
pubmed-article:6539589lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:6539589lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:6539589pubmed:issue3lld:pubmed
pubmed-article:6539589pubmed:dateCreated1984-6-28lld:pubmed
pubmed-article:6539589pubmed:abstractTextThe difference in the hearing threshold before and after treatment with cis-diaminnedichloroplatinum (DDP) is analysed in 69 patients. Hearing loss due to DDP treatment is mainly limited to 8,000 Hz and the incidence is about 40%. The effect of DDP is dose-related, although even at the lowest dose 20% of the patients are affected. The age of the patients is not an important factor. Loss of hearing due to DDP treatment occurs independent of any pre-existent hearing loss although those patients with great pre-existent hearing loss do not show a further loss. Of the patients with hearing loss, 39% show a difference of 20 dB or more between the left and the right ear. Hearing loss due to DDP is of minor importance compared with many of the other side-effects of DDP.lld:pubmed
pubmed-article:6539589pubmed:languageenglld:pubmed
pubmed-article:6539589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6539589pubmed:citationSubsetIMlld:pubmed
pubmed-article:6539589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6539589pubmed:statusMEDLINElld:pubmed
pubmed-article:6539589pubmed:issn0302-9530lld:pubmed
pubmed-article:6539589pubmed:authorpubmed-author:RodenburgMMlld:pubmed
pubmed-article:6539589pubmed:authorpubmed-author:BrocaarM PMPlld:pubmed
pubmed-article:6539589pubmed:authorpubmed-author:TangeR ARAlld:pubmed
pubmed-article:6539589pubmed:authorpubmed-author:ConijnE AEAlld:pubmed
pubmed-article:6539589pubmed:authorpubmed-author:van ZeijlL...lld:pubmed
pubmed-article:6539589pubmed:issnTypePrintlld:pubmed
pubmed-article:6539589pubmed:volume239lld:pubmed
pubmed-article:6539589pubmed:ownerNLMlld:pubmed
pubmed-article:6539589pubmed:authorsCompleteYlld:pubmed
pubmed-article:6539589pubmed:pagination255-62lld:pubmed
pubmed-article:6539589pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:meshHeadingpubmed-meshheading:6539589-...lld:pubmed
pubmed-article:6539589pubmed:year1984lld:pubmed
pubmed-article:6539589pubmed:articleTitleAnalysis of hearing loss due to cis-diamminedichloroplatinum-II.lld:pubmed
pubmed-article:6539589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6539589pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed